Cancer Treatment and Immunotherapy during Pregnancy

Area of Science:

• Oncology
• Maternal-Fetal Medicine
• Immunotherapy

Background:

• Increasing incidence of cancer during pregnancy.
• Growing use of immunotherapy for cancer treatment.
• Ethical and therapeutic challenges in treating pregnant cancer patients.

Purpose of the Study:

• To review oncology drug use in gestational cancers.
• To assess appropriateness and timing of treatments.
• To evaluate potential effects on mother and fetus.

Main Methods:

• Literature review of studies on gestational cancer treatment.
• Analysis of oncological drug administration during pregnancy.
• Examination of treatment timing and safety considerations.

Main Results:

• Oncological treatments (drugs, radiation, surgery) are case-dependent.
• Specific focus on the use and effects of immunotherapy during pregnancy.
• Studies indicate delaying oncological drug administration until post-first trimester is often advised.

Conclusions:

• Careful consideration of treatment timing is crucial for maternal and fetal well-being.
• Immunotherapy and other cancer drugs present unique challenges in pregnancy.
• Postponing treatment until after the first trimester is a key consideration.